Case Study: Abbott makes FreeStyle Libre the top prescribed CGM with GALE Partners

Abbott makes FreeStyle Libre the top prescribed CGM with Gale Partners

Abbott, a major healthcare company, faced the challenge of low adoption for its FreeStyle Libre continuous glucose monitor (CGM) despite a large diabetes community. Their competitor was more recognizable and had a larger media budget. Abbott partnered with the vendor, GALE Partners, to find a new digital approach to connect with people with diabetes and increase prescriptions.

GALE Partners implemented a solution using social listening to discover the audience preferred hearing from trusted peers. They created an always-on social media strategy featuring real FreeStyle Libre users sharing their stories. This genuine approach, combined with innovative lifestyle photography, created a deep emotional connection. As a result, paid social became the number two sales driver for the product in 2022, surpassing traditional advertising. This effort, led by GALE Partners, made FreeStyle Libre the top prescribed CGM and provided more people with access to the life-saving technology.

Abbott